Phosplatin Therapeutics Inc.
Pharmaceutical company · New York, United States
Phosplatin Therapeutics Inc. is a pharmaceutical company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $37 million sold in a notice filed in 2021.
Profile compiled from public records. Is this your company? Request a correction or update
Phosplatin Therapeutics at a glance
Typepharmaceutical company
HeadquartersNew York, United States
SEC CIK1757705
What does Phosplatin Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $37.3 million sold (2021).
Frequently asked questions about Phosplatin Therapeutics
Where is Phosplatin Therapeutics headquartered?
Phosplatin Therapeutics Inc. is headquartered in New York, United States.
What does Phosplatin Therapeutics do?
Phosplatin Therapeutics Inc. is a pharmaceutical company.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences